Guardian Capital Advisors LP Imv Inc. Transaction History

Guardian Capital Advisors LP

  • $967 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.56 - $1.45 $4,760 - $12,325
-8,500 Reduced 10.74%
70,664 $41,000
Q4 2019

Feb 13, 2020
SELL
$2.15 - $3.1 $12,831 - $18,500
-5,968 Reduced 7.01%
79,164 $351,000
Q2 2018

Aug 14, 2018
BUY
$4.42 - $7.13 $376,283 - $606,991
85,132 New
85,132 $521,000

About IMV Inc.

IMV Quotes by TradingView
  • Ticker IMV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,452,200
  • Description
  • IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...
More about IMV
Track This Portfolio

Track Guardian Capital Advisors LP Portfolio

Follow Guardian Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email